Publication: Correction to: the use of modified rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study
dc.contributor.coauthor | Tutuncu, Mesude | |
dc.contributor.coauthor | Dogan, Burcu V. | |
dc.contributor.coauthor | Uygunoglu, Ugur | |
dc.contributor.coauthor | Kale Icen, Nilufer | |
dc.contributor.coauthor | Elmali, Ayse Deniz | |
dc.contributor.coauthor | Coban, Eda | |
dc.contributor.coauthor | Alpaslan, Bengi G. | |
dc.contributor.coauthor | Soysal, Aysun | |
dc.contributor.kuauthor | Altıntaş, Ayşe | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.unit | Koç University Hospital | |
dc.date.accessioned | 2024-12-29T09:36:06Z | |
dc.date.issued | 2023 | |
dc.description.abstract | The 6th author name and affiliation was incorrectly published in the original publication. The complete correct name and affiliation is given below. Ayse Deniz Elmali Affiliation: Istanbul University, Istanbul Faculty of Medicine, Neurology Department, Istanbul, Turkey Also, the last author name was spelled incorrectly in the original publication. The complete correct name should read as follows Aysun Soysal The original article has been corrected. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 5 | |
dc.description.openaccess | All Open Access | |
dc.description.openaccess | Bronze Open Access | |
dc.description.publisherscope | International | |
dc.description.volume | 123 | |
dc.identifier.doi | 10.1007/s13760-022-01897-1 | |
dc.identifier.issn | 0300-9009 | |
dc.identifier.quartile | Q3 | |
dc.identifier.scopus | 2-s2.0-85125724529 | |
dc.identifier.uri | https://doi.org/10.1007/s13760-022-01897-1 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/21944 | |
dc.identifier.wos | 765654200001 | |
dc.keywords | Adjuvants, immunologic | |
dc.keywords | Adolescent | |
dc.keywords | Adult | |
dc.keywords | Disease progression | |
dc.keywords | Female | |
dc.keywords | Glatiramer acetate | |
dc.keywords | Humans | |
dc.keywords | Immunosuppressive agents | |
dc.keywords | Interferon beta-1a | |
dc.keywords | Male | |
dc.keywords | Middle aged | |
dc.keywords | Multiple sclerosis, relapsing-remitting | |
dc.keywords | Retrospective studies | |
dc.keywords | Treatment failure | |
dc.keywords | Young adult | |
dc.language | en | |
dc.publisher | Springer Science and Business Media Deutschland Gmbh | |
dc.source | Acta Neurologica Belgica | |
dc.subject | Multiple sclerosis | |
dc.subject | Magnetic resonance imaging | |
dc.subject | Clinically isolated syndrome | |
dc.title | Correction to: the use of modified rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study | |
dc.type | Other | |
dc.type.other | Correction | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Altıntaş, Ayşe |